COVID-19 updates show total cases hit 3.2 million globally. Pharmaceutical company Abbott has developed a test for detecting COVID-19. They claim that the test has 99.6% specificity and 100% sensitivity.
The test measures the amount of immunoglobulin G antibodies against SARS-CoV-2 which are antibodies that the body builds up in the later stages of infection. They cause coronavirus disease.
The Food and Drug Administration (FDA) has given the approval to use this test in the United States and the European Union has approved it in Europe.
The World Health Organization (WHO) has warned governments against issuing “immunity passports” to those who have antibodies to SARS-CoV-2. The organization explains that there is no evidence that these antibodies can protect against infection in the future.
Vietnam officials said that they successfully beat the outbreak because they strongly responded during its early phases. The Vietnamese government denied entry and suspended issuing tourist visas to citizens.
The Centers for Disease Control and Prevention (CDC) have recently added new symptom categories to the existing criteria. The organization revealed that a person may develop COVID-19 if they have cough and shortness of breath or at least two of the symptoms including fever, chills, repeated shaking with chills, muscle pain, headache, a sore throat, and a net loss of taste and smell.